Tag: Taiho Oncology’s

February 25, 2019 Off

Tahio Oncology’s Lonsurf approved as treatment of advanced gastric and GEJ cancer in the USA

Taiho Oncology got aproval to have its Lonsurf as a treatment for adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma in the United States.

September 22, 2015 Off

Taiho Oncology’s Lonsurf approved in USA

By Dino Mustafić

The U. S. Food and Drug Administration approved Taiho Oncology’s Lonsurf for the treatment of patients with metastatic colorectal cancer who…